Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 218 for “"buprenorphine"”.

  1. Investigation Into Pharmacokinetics and Disposition of Buprenorphine and Related Opioids and Pharmacological Effects of Buprenorphine-O-Glucuronide

    … and the pharmacodynamic contribution of buprenorphine glucuronide (BUPE-G). Methods: A sensitive LC–MS/MS method was developed and validated for the simultaneous quantification of eight opioids and seven glucuronide metabolites. Pharmacokinetic studies were conducted in rats (0.2 mg/kg, …

    houston Repository record for Investigation Into Pharmacokinetics and Disposition of Buprenorphine and Related Opioids and Pharmacological Effects of Buprenorphine-O-Glucuronide (opens in a new tab) Embargoed until 2028-05-01

  2. Buprenorphine metabolism by preterm placentas: A pilot study

    … the major enzyme responsible for metabolism of buprenorphine to nor-buprenorphine in human preterm placentas and to elucidate whether the development/gestational age of the placenta affects metabolism of buprenorphine. The estimated apparent Km did not appear to change with gestational age …

    utmb Repository record for Buprenorphine metabolism by preterm placentas: A pilot study (opens in a new tab)

  3. Emerging Patterns of Substance Use and Buprenorphine Nonadherence

    … called the Trial of Adherence Application for Buprenorphine Treatment (TAAB) to evaluate the association between methamphetamine use and buprenorphine adherence among people receiving buprenorphine as treatment for OUD. Among this study population, we found a significant positive association …

    washington Repository record for Emerging Patterns of Substance Use and Buprenorphine Nonadherence (opens in a new tab)

  4. Counseling interventions with buprenorphine for treatment of opioid use disorders

    … opioid use disorder (OUD) (Bart, 2012). While buprenorphine, an approved medication for the treatment of OUD, has a wide research base to support its efficacy, there is little research or guidance on behavioral interventions to use in conjunction with the medication. Investigating clients' …

    vt Repository record for Counseling interventions with buprenorphine for treatment of opioid use disorders (opens in a new tab)

  5. Barriers to Treatment with Buprenorphine for Opioid Addiction in New Mexico

    … frequent and impactful barriers faced by the buprenorphine prescribers and non-prescribers for treating the opioid addicted population in NM. The research study has one specific aim that is descriptive and exploratory in nature: To create a new survey that will later be used to assess the …

    unm Repository record for Barriers to Treatment with Buprenorphine for Opioid Addiction in New Mexico (opens in a new tab)

  6. Barriers to HIV and HCV Screening in the TRUST Buprenorphine Clinic

    As the opioid epidemic continues in Philadelphia, buprenorphine clinics are becoming a necessary mainstay in treatment of these patients. HIV and HCV rates are rising throughout the city due to injection drug use, and buprenorphine clinics could be a bridge to therapy for these conditions as well. …

    temple Repository record for Barriers to HIV and HCV Screening in the TRUST Buprenorphine Clinic (opens in a new tab)

  7. Evaluating Buprenorphine as a Treatment for Kratom Withdrawal: A Systematic Review [poster]

    … are very limited (Henningfield et al., 2023). Buprenorphine has been shown to be effective for opioid withdrawal and is reported in cases with kratom use; however, standardized dosing/assessment and effectiveness for kratom withdrawal are lacking (Dunn & Huhn, 2024).

    texas-state Repository record for Evaluating Buprenorphine as a Treatment for Kratom Withdrawal: A Systematic Review [poster] (opens in a new tab)

  8. The Effect of Buprenorphine on HIV RNA Load Distribution and Viral Suppression

    … and can delay time to viral suppression. Use of buprenorphine (BUP), an opioid agonist therapy, may improve HIV outcomes in HIV care settings. We estimated the marginal distribution of HIV viral loads and the prevalence of viral suppression by BUP status. In the Johns Hopkins HIV Clinical Cohort, …

    jhu Repository record for The Effect of Buprenorphine on HIV RNA Load Distribution and Viral Suppression (opens in a new tab)

  9. Buprenorphine and Methadone in pregnancy: effects on the mother, fetus and neonate.

    … study aimed to assess the efficacy and safety of buprenorphine maintenance for the treatment of illicit opioid dependence during pregnancy. Parameters investigated assessed pregnancy progression and Neonatal Abstinence Syndrome (NAS) compared to methadone maintenance and non-opioid exposed control …

    adelaide Repository record for Buprenorphine and Methadone in pregnancy: effects on the mother, fetus and neonate. (opens in a new tab)

  10. Physician-initiated buprenorphine treatment for opioid use disorder in Nevada emergency departments

    … use and the risk of opioid overdose deaths. Buprenorphine, a prescription medication to treat OUD, can be initiated same day a patient is diagnosed with OUD without the need for opioid abstinence. But it remains underused in the outpatient setting because of regulatory and provider-level …

    unr Repository record for Physician-initiated buprenorphine treatment for opioid use disorder in Nevada emergency departments (opens in a new tab)

  11. Leveraging clinical material: an ethnography of buprenorphine-based treatment in greater Pittsburgh

    Studies have found that buprenorphine-based treatment reduces morbidity and mortality among Opioid Use Disorder (OUD) patients (Wakeman et al. 2020), and a growing consensus about the efficacy of this medication has led to substantial public and private investments in increasing its availability …

    penn Repository record for Leveraging clinical material: an ethnography of buprenorphine-based treatment in greater Pittsburgh (opens in a new tab)

  12. CONTINGENCY MANAGEMENT FOR OPIOID USE DISORDER BUPRENORPHINE TREATMENT ENGAGEMENT: 3-MONTH OUTCOMES

    … disorder exhibit difficulty sustaining prolonged buprenorphine treatment engagement. Contingency management (CM; incentives) may serve to increase the reinforcing value of treatment itself, but most buprenorphine CM studies delivered incentives more frequently than in typical outpatient practice. …

    rowan Repository record for CONTINGENCY MANAGEMENT FOR OPIOID USE DISORDER BUPRENORPHINE TREATMENT ENGAGEMENT: 3-MONTH OUTCOMES (opens in a new tab)

  13. Prenatal buprenorphine exposure reduces expression of myelin proteins in neonatal longs-Evans rat

    … and NAS is still unclear, it is thought that buprenorphine, one of the main substances used to treat OUD in pregnant women, may feed into the development of NAS, which may affect mental and physiological development and cause other health problems. Via understanding the developmental impact of …

    marshall Repository record for Prenatal buprenorphine exposure reduces expression of myelin proteins in neonatal longs-Evans rat (opens in a new tab)

  14. Social determinants of health and buprenorphine adherence among individuals with opioid use disorder

    … Model for Vulnerable Populations (BMVP), on buprenorphine adherence among individuals with opioid use disorder (OUD). It also assessed social risk factors discussed clinically and the resources provided. A cross-sectional survey was administered via a Qualtrics® panel of U.S. adults receiving …

    texas Repository record for Social determinants of health and buprenorphine adherence among individuals with opioid use disorder (opens in a new tab)

  15. Buprenorphine Dose and Opioid Use Disorder-Related Outcomes Among Pregnant and Postpartum Individuals

    … for opioid use disorder (MOUD), including buprenorphine, are the gold standard treatment for opioid use disorder (OUD) during pregnancy and are critical for reducing opioid overdose rates during an era when fentanyl and other high-potency synthetic opioids (HPSOs) are a leading cause of …

    jhu Repository record for Buprenorphine Dose and Opioid Use Disorder-Related Outcomes Among Pregnant and Postpartum Individuals (opens in a new tab)

  16. Development of the Self-efficacy for Medication Adherence for Buprenorphine (SEMA-B) Assessment

    … are self-efficacy and medication adherence. Buprenorphine is a relatively new medication that has shown significant efficacy is treatment of opiate addiction. Successful treatment also requires appropriate adherence to taking buprenorphine as prescribed. The impact of self-efficacy on …

    marquette Repository record for Development of the Self-efficacy for Medication Adherence for Buprenorphine (SEMA-B) Assessment (opens in a new tab)

  17. Perinatal Buprenorphine Effects on Offspring Growth, Opioid Withdrawal, and Brain Morphology in Rats

    … (OUD) impacts 5.6 million people in the US. Buprenorphine (BUP) is a commonly prescribed opioid medication used to treat OUD, including in pregnant women. However, opioid use during pregnancy is associated with poorer infant outcomes including reduced fetal growth, neurodevelopmental …

    etsu Repository record for Perinatal Buprenorphine Effects on Offspring Growth, Opioid Withdrawal, and Brain Morphology in Rats (opens in a new tab) Download PDF for Perinatal Buprenorphine Effects on Offspring Growth, Opioid Withdrawal, and Brain Morphology in Rats (opens in a new tab)

  18. Becoming Normal: The Social Construction of Buprenorphine and New Attempts to Medicalize Addiction

    … dissertation analyzes the social construction of buprenorphine, a medication being used to treat addiction to opioids, to better understand the processes of medicalization. Buprenorphine was central the passage of the Drug Addiction Treatment Act of 2000, a law which overturned an almost one …

    cuny-grad Repository record for Becoming Normal: The Social Construction of Buprenorphine and New Attempts to Medicalize Addiction (opens in a new tab)

Page 1 of 11